Home » Could the Difference Between Normal and Malignant Stem Cells Eradicate Cancer?

TITLE

Could the Difference Between Normal and Malignant Stem Cells Eradicate Cancer?

AUTHOR(S)

Ivanovic, Zoran

PUB. DATE

October 2013

SOURCE

Scripta Medica;Oct2013, Vol. 44 Issue 2, p74

SOURCE TYPE

Academic Journal

DOC. TYPE

Editorial

ABSTRACT

The authors discuss the role of normal stem cells in the eradication of cancer. They consider cellular therapy as a real medical revolution prompted by stem cell research in the 21st century. They describe the commonality between normal and cancer stem cells based on the findings of stem cell research.

Patient/caregiver out-of pocket costs associated with hematopoietic cell transplantation (HCT) are not well known. We conducted a pilot study to evaluate patient/caregiver out-of-pocket costs in the first 3 months after allogeneic HCT. Thirty patients were enrolled at three sites. Before HCT,...

There is a ying/yang to most biological therapies, and the balance of efficacy versus toxicity is delicate and sometimes difficult to achieve in favor of the patients. When the therapeutic window is wide, these therapies can be used in the majority of patients, but when the therapeutic window is...

Human embryonic stem cells are derived from the inner cell mass of a blastocyst-stage embryo. They hold a huge promise for cell therapy with their self-renewing ability and pluripotency, which is known as the potential to differentiate into all cell types originating from three embryonic germ...

The article discusses research being done on a new way to more safely reprogram adult stem cells which can provide a virtually limitless supply of embryonic-like stem cells called induced pluripotent stem (iPS) cells. It references studies by Andras Nagy and Keisuke Kaji, published in "Nature."...

Cell therapy is emerging as a new strategy to circumvent the adverse effects of heart disease. Many experimental and clinical studies investigating the transplantation of cells into the injured myocardium have yielded promising results. Moreover, data from these reports show that transplanted...

In this article, the authors discuss the study of L. Gattinoni and colleagues on memory stem cells (TSCM). The authors say that the study, which was published in the October 2011 issue of the journal "Nature Medicine," reports the identification of such cells in humans, describing them...

Lung stem/progenitor cells are potentially useful for regenerative therapy, for example in repairing damaged or lost lung tissue in patients. Several optical imaging methods and probes have been used to track how stem cells incorporate and regenerate themselves in vivo over time. However, these...

Enabling stem cell-targeted therapies requires an understanding of how to create local microenvironments (niches) that stimulate endogenous stem cells or serve as a platform to receive and guide the integration of transplanted stem cells and their derivatives. In vivo, the stem cell niche is a...

Induced pluripotent stem cells (iPSCs) can be generated from patients with specific diseases by the transduction of reprogramming factors and can be useful as a cell source for cell transplantation therapy for various diseases with impaired organs. However, the low efficiency of iPSC derived...